NEW YORK, NY, May 08, 2013 (Press-News.org) "21" is a comedy about modern family dynamics. A rambunctious Puerto Rican family takes their socially-conscious 21-year-old college graduate to a casino in upstate New York for a celebration. His eccentric parents are hoping this trip will help unify the whole family, unaware that their son is about to drop a bombshell on them. The cast includes Dalia Davi, Abdel Gonzalez, Sandor Juan and Frank Rodriguez.
Tickets for "21" start at $27 and may be reserved online at www.repertorio.org or by phone, 1-212-225-9999.
"21" is sponsored by MetLife Foundation
Now on its 14th edition, 'MetLife Nuestras Voces' has brought awareness to dozens of Latino plays and playwrights throughout the nation. The competition is responsible for the production of 13 plays at Repertorio Espanol. In addition, many of the competition's finalists have gone on to receive readings, workshops and full productions at theaters such as Second Stage and Rattlestick in New York, Teatro Vista in Chicago and Signature Theatre in Virginia. Playwrights have subsequently received fellowships and residencies at companies such as The Public Theatre in New York and Goodman Theatre in Chicago, respectively. Playwrights that have participated in the competition have won ACE and HOLA Awards (Lina Gallegos, Carlos Lacamara, and Jorge Gonzalez) and the Pulitzer Prize for Drama (Quiara Alegria Hudes). The competition has distributed $100,000 in cash awards to Latino playwrights.
Repertorio Espanol was founded in 1968 to introduce the best of Latin American, Spanish and Hispanic-American theatre in distinctive, quality productions, and to bring theatre to a broad audience in New York City and across the country, including seniors, students and Hispanics of all national backgrounds.
Website: http://www.repertorio.org
Repertorio Espanol Announces the World Premiere of Vincent Toro's "21," Winning Play of the 2011 'MetLife Nuestras Voces' National Latino Playwriting Competition
"21," directed by Jose Zayas, will be presented in English and Spanish with captions in both languages. Previews begin on Thursday, May 16, 2013 and the World Premiere will take place on Monday, May 20, 2013.
2013-05-08
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Bruegger's Bagels' Summer Menu Line-Up is Hot, Cool and Sweet
2013-05-08
Today, Bruegger's Bagels, known for its authentic, New York-style bagels baked fresh in each of its bakeries, introduces a new summer menu unlike any others before with new flavors that are at once bold, spicy, sweet and savory.
Executive Chef Philip Smith added completely new flavors and ingredients to the menu this season, reflecting the bagel bakery's commitment to menu items that are flavorful and on trend while staying true to what keeps guests coming back every day.
The innovative menu items - available today in all 300-plus bagel bakeries - include:
- ...
Canadian Board Diversity Council (CBDC) Chooses InfoTech Solutions for Business for the Diversity 50 2013 Application Process Project
2013-05-08
InfoTech, a leading software house and system solutions company, has completed and delivered CBDC with a customized white labeled version of the Diverse Director Data Source system (also known as 3D) to support CBDC's Diversity 50 2013 Application process.
The Diversity 50 is a brand new resource for directors and search firms. It is Canada's first-ever database of qualified diverse men and women from across Canada with strong competencies that align with the requirements of many Canadian boards (www.boarddiversity.ca/diversity-50).
The customized solution also includes ...
New class of drug targets skin cancer
2013-05-07
7 May, 2013 -- Sydney, Australia:
A new class of drug targeting skin cancer's genetic material has been successfully tested in humans for the first time, opening the way to new treatments for a range of conditions from skin cancers to eye diseases.
The research involves the drug Dz13, a targeted molecular therapy, which was developed at the University of New South Wales (UNSW) and has now been found to be safe in a clinical trial of patients with the common skin cancer, basal-cell carcinoma.
"This is the first report of a drug of this type to be used in humans," ...
New perspective needed for role of major Alzheimer's gene
2013-05-07
Scientists' picture of how a gene strongly linked to Alzheimer's disease harms the brain may have to be revised, researchers at Washington University School of Medicine in St. Louis have found.
People with harmful forms of the APOE gene have up to 12 times the risk of developing Alzheimer's disease compared with those who have other variations of the gene.
Many researchers believe that the memory loss and cognitive problems of Alzheimer's result from the buildup over many years of brain amyloid plaques. The plaques are made mostly of a sticky substance called amyloid ...
A giant leap to commercialization of polymer solar cell
2013-05-07
A polymer solar cell is a type of thin film solar cells made with polymers that produce electricity from sunlight by the photovoltaic effect. Most current commercial solar cells are made from a highly purified silicon crystal. The high cost of these silicon solar cells and their complex production process has generated interest in developing alternative photovoltaic technologies.
Compared to silicon-based devices, PSCs are lightweight (which is important for small autonomous sensors), solution processability (potentially disposable), inexpensive to fabricate (sometimes ...
New insights into Ebola infection pave the way for much-needed therapies
2013-05-07
The Ebola virus is among the deadliest viruses on the planet, killing up to 90% of those infected, and there are no approved vaccines or effective therapies. A study published by Cell Press on May 7th in the Biophysical Journal reveals how the most abundant protein making up the Ebola virus—viral protein 40 (VP40)—allows the virus to leave host cells and spread infection to other cells throughout the human body. The findings could lay the foundation for the development of new drugs and strategies for fighting Ebola infection.
"Little research is available on how the ...
Protecting the heart health of diabetic patients
2013-05-07
Diabetics have an increased risk of developing coronary artery disease and plaque build-up in their arteries, even if they receive cholesterol-lowering therapies. New research published in the May 7th issue of the Cell Press journal Cell Metabolism reveals that high blood sugar levels also boost the production of inflammatory cells, which contribute to plaque build-up in blood vessels. The researchers identify the cause of this increased production in inflammatory cells and find that blocking this new pathway could help safeguard the heart health of diabetic patients.
"We ...
Biomechanical performances of old-fashioned leather and modern football helmets
2013-05-07
Charlottesville, VA (May 7, 2013). Researchers at the Center for Injury Biomechanics at Virginia Tech in Blacksburg, Virginia compared the relative safety afforded by two 1930-vintage leather football helmets and 10 modern football helmets during impacts to players' heads. These researchers found that all 10 modern helmets provided significantly more protection than leather helmets used in the first half of the twentieth century, and demonstrated that differences also exist between modern helmets. Details on their methods and findings are found in "Biomechanical performance ...
Type 1 diabetes and heart disease linked by inflammatory protein
2013-05-07
NEW YORK, NY (May 7, 2013) — Type 1 (insulin-dependent) diabetes appears to increase the risk of heart disease, the leading cause of death among people with high blood sugar, partly by stimulating the production of calprotectin, a protein that sparks an inflammatory process that fuels the buildup of artery-clogging plaque. The findings, made in mice and confirmed with human data, suggest new therapeutic targets for reducing heart disease in people with type 1 diabetes. Led by Columbia University Medical Center (CUMC) researchers in collaboration with investigators at New ...
Study of new 'bone-head' hints at higher diversity of small dinosaurs
2013-05-07
Toronto, Canada – Scientists have named a new species of bone-headed dinosaur (pachycephalosaur) from Alberta, Canada. Acrotholus audeti (Ack-RHO-tho-LUS) was identified from both recently discovered and historically collected fossils. Approximately six feet long and weighing about 40 kgs in life, the newly identified plant-eating dinosaur represents the oldest bone-headed dinosaur in North America, and possibly the world. Research describing the new species is published May 7, 2013 in the journal Nature Communications.
Acrotholus means "high dome", referring to its ...
LAST 30 PRESS RELEASES:
Floating solar panels could support US energy goals
Long before the L.A. fires, America’s housing crisis displaced millions
Breaking barriers: Collaborative research studies binge eating disorders in older Hispanic women
UVA receives DURIP grant for cutting-edge ceramic research system
Gene editing extends lifespan in mouse model of prion disease
Putting a lid on excess cholesterol to halt bladder cancer cell growth
Genetic mutation linked to higher SARS-CoV-2 risk
UC Irvine, Columbia University researchers invent soft, bioelectronic sensor implant
Harnessing nature to defend soybean roots
Yes, college students gain holiday weight too—but in the form of muscle not fat
Beach guardians: How hidden microbes protect coastal waters in a changing climate
Rice researchers unlock new insights into tellurene, paving the way for next-gen electronics
New potential treatment for inherited blinding disease retinitis pigmentosa
Following a 2005 policy, episiotomy rates have reduced in France without an overall increase in anal sphincter injuries during labor, with more research needed to confirm the safest rate of episiotomi
Rats anticipate location of food-guarding robots when foraging
The American Association for Anatomy announces their Highest Distinctions of 2025
Diving deep into dopamine
Automatic speech recognition on par with humans in noisy conditions
PolyU researchers develop breakthrough method for self-stimulated ejection of freezing droplets, unlocking cost-effective applications in de-icing
85% of Mexican Americans with dementia unaware of diagnosis, outpacing overall rate
Study reveals root-lesion nematodes in maize crops - and one potential new species
Bioinspired weather-responsive adaptive shading
Researchers uncover what drives aggressive bone cancer
Just as Gouda: Improving the quality of cheese alternatives
Digital meditation to target employee stress
Electronic patient-reported outcome system implementation in outpatient cardiovascular care
Knowledge and use of menthol-mimicking cigarettes among adults in the US
Uncurling a single DNA molecule and gluing it down helps sharpen images
Medicare Advantage beneficiaries did not receive more dental, vision or hearing care
Green hydrogen: Big gaps between ambition and implementation
[Press-News.org] Repertorio Espanol Announces the World Premiere of Vincent Toro's "21," Winning Play of the 2011 'MetLife Nuestras Voces' National Latino Playwriting Competition"21," directed by Jose Zayas, will be presented in English and Spanish with captions in both languages. Previews begin on Thursday, May 16, 2013 and the World Premiere will take place on Monday, May 20, 2013.